4//SEC Filing
Kaufmann Gunnar F. 4
Accession 0001209191-21-010907
CIK 0001260990other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 6:00 PM ET
Size
5.7 KB
Accession
0001209191-21-010907
Insider Transaction Report
Form 4
Kaufmann Gunnar F.
Chief Scientific Officer
Transactions
- Award
Stock Option
2021-02-11+253,000→ 253,000 totalExercise: $7.05Exp: 2031-02-11→ Common Stock (253,000 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the shares subject to the stock options shall vest on first anniversary of the date of grant, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment or service with the Issuer on each such date.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001786754
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 6:00 PM ET
- Size
- 5.7 KB